“Overcoming breast cancer drug resistance with mTOR inhibitors”. Could it be a myth or a real possibility in the short-term future?

By Margariti Nadia  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 599-606

Springer Publishing Company

Access to resources Recommend Favorite

Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?

By Galimberti Viviana  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 819-825

Springer Publishing Company

Access to resources Recommend Favorite

Should bisphosphonates be utilized in the adjuvant setting for breast cancer?

By Lipton Allan  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 627-636

Springer Publishing Company

Access to resources Recommend Favorite

Hypothesis: is antibiotic use associated with breast cancer?

By Velicer Christine M.  

Cancer Causes and Control, Vol. 14, Iss. 8, 2003-01 ,pp. : 739-747

Springer Publishing Company

Access to resources Recommend Favorite

Is there a role for ovarian function suppression in operable breast cancer?

By Sparano Joseph  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 311-313

Springer Publishing Company

Access to resources Recommend Favorite